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Gene Transfer into Hepatocytes Using Asialoglycoprotein Receptor 
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Tetra-Antennary Galactose Ligand 
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We have constructed an artificial ligand for the hepatocyte-specific asialoglycoprotein receptor for the 
purpose of generating a synthetic delivery system for DNA. This ligand has a tetra-antennary structure, 
containing four terminal galactose residues on a branched carrier peptide. The carbohydrate residues 
of this glycopeptide were introduced by reductive coupling of lactose to the a- and €-amino groups of 
the two N-terminal lysines on the carrier peptide. The C-terminus of the peptide, containing a cysteine 
separated from the branched N-terminus by a 10 amino acid spacer sequence, was used for conjugation 
to 3-(2-pyridyldithio)propionate-modified polylysine via disulfide bond formation. Complexes containing 
plasmid DNA bound to these galactose-polylysine conjugates have been used for asialoglycoprotein 
receptor-mediated transfer of a luciferase gene into human (HepG2) and murine (BNL CL.2) hepatocyte 
cell lines. Gene transfer was strongly promoted when amphipathic peptides with pH-controlled 
membrane-disruption activity, derived from the N-terminal sequence of influenza virus hemagglutinin 
HA-2, were also present in these DNA complexes. Thus, we have essentially borrowed the small functional 
domains of two large proteins, asialoglycoprotein and hemagglutinin, and assembled them into a 
supramolecular complex to generate an efficient gene-transfer system. 
INTRODUCTION 
During the last few years gene-transfer methods have 
been developed that adopt natural receptor-mediated 
endocytosis pathways for the delivery of DNA into 
eukaryotic cells. Ligands for cellular receptors, such as 
transferrin (1, 2), viral proteins (3), insulin bound to 
albumin (4 ) ,  or asialoorosomucoid (5, 6) have been 
successfully used for the import of DNA molecules. For 
this purpose these ligands have been conjugated to DNA- 
binding compounds, such as a polycation or an interca- 
lating agent. Incubating DNA with these protein conju- 
gates generates ligand-coated DNA which can bind 
receptors on the cell surface and is subsequently inter- 
nalized. Small synthetic, rationally designed compounds 
that bind specifically to a cellular receptor may be useful, 
well-defined alternatives for large protein ligands. 
In this paper we describe the synthesis of polylysine 
conjugates containing an artificial ligand for the asialo- 
glycoprotein receptor (7). This hepatocyte-specific re- 
ceptor recognizes exposed galactose on serum glycoproteins 
that have lost the terminal sialic acids and rapidlyremoves 
these glycoproteins from the circulation to the liver. The 
artificial ligand we designed displays four galactoside 
residues on a branched carrier peptide possessing a 
C-terminal cysteine as a ligation site for coupling to the 
DNA-binding polycation polylysine. Using this protein- 
free, synthetic polylysine conjugate, luciferase gene trans- 
fer into cultured hepatocytes is possible with an efficiency 
similar to that achieved with a natural ligand, asialofetuin, 
conjugated to polylysine. One limit to receptor-mediated 
gene delivery may be the accumulation of the delivered 
DNA complexes in intracellular vesicles (2, 3, 8). To 
overcome this barrier, we have developed strategies that 
utilize the endosome disruption activity of either defective 
adenovirus particles (9, 10) or synthetic, amphipathic 
peptides (111, derived from the N-terminus of the influenza 
virus hemagglutinin HA-2 protein (12). Further goals of 
this work have been to prepare DNA complexes containing 
both the synthetic galactose-ligand and the amphipathic 
peptides, and to subsequently investigate whether these 
protein-free DNA complexes have improved gene transfer 
efficiencies. 
EXPERIMENTAL PROCEDURES 
Materials and Conjugates. The DNA plasmid 
pCMVL, containing the Photinus pyralis luciferase gene 
under control of the cytomegalovirus enhancer/promoter, 
was prepared by removing the BamHI insert of the plasmid 
pSTCX556 (131, treating the plasmid with Klenow frag- 
ment, and ligating with the HindIIIISspI and Klenow- 
treated fragment from the plasmid pRSVL (14), which 
contains the sequence coding for luciferase. Human 
transferrin-poly@-lysine) conjugates with an average chain 
length of 190 lysines (TfpL19Ol) or 290 lysines (TfpL290) 
were prepared as described (15). Mouse transferrin-poly- 
(L-lysine) conjugates (mTfpL290) were synthesized using 
the method described in ref 1. Conjugate InflupL, 
containing the peptide derived from influenza virus 
hemagglutinin (Gly-Leu-Phe-Glu- Ala-Ile- Ala-Gly-Phe-Ile- 
Glu- Asn-Gly-Trp-Glu-Gly-Met-Ile- Asp-Gly-Gly-Gly- 
Cys) coupled to polylysine plysaw, was synthesized as 
described in ref 11. Synthesis of N'-lactosylated polylysine 
(pLys-lactose) was performed as follows: to a solution of 
16.5 mg (0.44 pmol) of pLyszw, acetate salt, in 0.46 mL of 
100 mM sodium acetate (pH 5.0) was added 90 mg (0.26 
mmol) of lactose (Sigma), which dissolved upon agitating 
within 30 min a t  37 "C. The solution was kept a t  this 
temperature while four 3-mg portions of sodium cy- 
anoborohydride were added in about 10-h intervals. The 
reaction mixture was left for an additional 21 h a t  37 "C; 
then 15 pL of acetic acid was added, and the reaction 
Abbreviations used: TfpL, transferrin-poly(L-lysine) con- 
jugate; AFpL, asialofetuin-poly(L-lysine) conjugate; pLyszoo and 
pLys2~0, poly(L-lysine) with an average chain length of 200 or 290 
lysine monomers; HEPES, 4-(2-hydroxyethyl)-l-piperazineethane- 
sulfonic acid; HBS, HEPES-buffered saline (150 m M  NaCl, 20 
mM HEPES, pH 7.3). 
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mixture was subjected to gel filtration (Sephadex G25- 
PD10) in 100 mM sodium acetate (pH 5.0). The product- 
containing fraction (identified by ninhydrin assay and 
staining with anisaldehyde after spotting l-pL samples 
on TLC plates) was dialyzed against 20 mM sodium acetate 
overnight and then against 0.05% acetic acid. Lyo- 
philization gave 26.5 mg of p L y s ~ ,  acetate salt, with about 
75-8076 of the Nf-lysine amino groups lactosylated, as 
determined by ninhydrin analysis and NMR analysis ['H 
NMR (D20, 250 MHz, solvent suppression): 6 (ppm) = 
4.51 (d, J = 7.2 Hz, galactose-lH), 4.22-4.34 (lysine a-H), 
4.1-4.22 (sugar H), 2.9-4.0 (lysine t-H and sugar H), 1.91 
(acetate, CHd, 1.1-2.0 (aliphatic CH2 of lysine)]. 
Assays. The amount of dithiopyridine linkers in 
modified asialofetuin or polylysine was determined after 
reduction of an aliquot with dithiothreitol followed by 
absorption measurement of released pyridine-Qthione a t  
340 nm. The polylysine content of fractions was estimated 
spectrophotometrically by ninhydrin assay. The amount 
of free mercapto groups in modified polylysine or peptides 
was determined using 5,5'-dithiobis(2-nitrobenzoic acid) 
(16) and measurement a t  412 nm. The asialofetuin content 
of fractions was determined by UV measurement a t  280 
nm and correction of the value (where necessary) by 
substraction of the corresponding UV absorption of 
dithioppidine or buffer a t  280 nm. Lactosylation was 
monitored by staining with anisaldehyde reagent @- 
anisaldehyde/sulfuric acid/ethanol, 1/ 1/ 18) on TLC plates 
(silica gel), by 'H-NMR analysis, and/or spectrophoto- 
metrically by the anthron assay (17) using lactosylated 
polylysine as standard. 
Asialofetuin-Polylysine Conjugate Synthesis. Asia- 
lofetuin-polylysine conjugate ( AFpL) was synthesized by 
coupling asialofetuin to polylysine via disulfide bonds after 
modification of asialofetuin with the bifunctional reagent 
succinimidyl3-(2-ppidyldithio)propionate (SPDP, Phar- 
macia) in asimilar fashion as described (I). To a solution 
of 100 mg (2.2 pmol) of asialofetuin (Sigma) in 4 mL of 100 
mM HEPES buffer, pH 7.9, was added 330 pL of a 15 mM 
ethanolic solution of SPDP (5.0 pmol) with vigorously 
mixing. After 1 h a t  room temperature, purification was 
performed by gel filtration (Sephadex G25; 100 mM 
HEPES buffer, pH 7.9) to give 5 mL of a solution of 1.4 
pmol of asialofetuin modified with 2.25 pmol of dithio- 
pyridine linker. This solution was mixed under an argon 
atmosphere with a solution of 0.33 pmol of poly(L-lysine) 
with an average chain length of 190 lysine monomers 
(pLys l~ ) ,  modified with 1.07 pmol of 3-mercaptopropi- 
onate groups as described in ref 1, in 6.5 mL of 200 mM 
HEPES buffer, pH 7.6. The reaction mixture was kept 
for 24 h a t  room temperature. Conjugates were isolated 
from the reaction mixture by cation-exchange chroma- 
tography (Mono S column HR 10/10, Pharmacia; gradient 
elution with buffer A, 50 mM HEPES, pH 7.9, and buffer 
B, buffer A plus 3 M NaC1). Sodium chloride was added 
to the reaction mixture (final concentration 0.6 M) before 
loading the column, and the gradient was started a t  this 
salt concentration. The product was eluted a t  a NaCl 
concentration of ca. 1.5 M. After dialysis against HBS, 
conjugates containing 0.24 pmol of pLyslW modified with 
0.52 pmol asialofetuin were obtained. 
Synthesis of Tetragalactose-Peptide-Polylysine 
Conjugate (ga1)lpL. ( A )  Lactosylated Peptide Ib .  
Freeze-dried, branched peptide la (3.5 mg, 1.92 pmol) with 
the sequence a,t-(Lys)Z-Lys-Gly-(Ser-Gly-Gly)3-[S-(2-py- 
ridylthio)lCys, synthesized by the Fmoc procedure (18, 
19) using an Applied Biosystems 431A peptide synthesizer 
and a,€-bis(Fmoc)-protected lysine (Bachem), was treated 
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with a solution of 7.85 mg (23 pmol) of lactose in 40 pL 
of 10 mM aqueous sodium acetate, pH 5 a t  37 "C. To the 
solution were added four 0.6 mg (10 pmol) portions of 
sodium cyanoborohydride a t  10-h intervals. After a total 
of 64 h a t  37 "C, 0.5 mL of HEPES, pH 7.3, and 15 mg of 
dithiothreitol were added. After 30 min, fractionation by 
gel filtration (Sephadex G10,12 X 130 mm, eluent 20 mM 
NaC1) under argon yielded a 3.6-mL solution of lactosy- 
lated peptide lb in the free mercapto form (1.73 pmol, 
according to an assay withEllman's reagent, an 84% yield). 
Samples of the modified peptide showed a color reaction 
with anisaldehyde, but no color reaction with ninhydrin; 
this is consistent with the assumption that all four 
N-terminal amino groups have been lactosylated. 'H- 
NMR analysis (D20, 250 MHz, solvent suppression) 
demonstrated that the group of five a-H signals, 6 (ppm) 
= 4.58 (1 H, Cys), 4.52 (3 H, 3 Ser), 4.35 (1 H, Lys), found 
in the spectrum of the precursor peptide is overlaid by the 
signal of four galactose-1H protons a t  4.51 ppm (4 H). 
Time-of-flight mass spectrum performed with a Bio Ion 
252Cf PD-MS instrument (Uppsala, Sweden) showed a 
major mass peak of 2473 (MH+ of product lb) and a minor 
peak of 2146 (presumably traces of tris-lactosylated 
peptide). 
(B)  3-Dithiopyridinepropionate-Modified Polylysine 
2. To a gel-filtered solution of 0.60 pmol of pLysz~,  
(hydrobromide, Sigma) in 1.2 mL of 100 mM HEPES 
buffer, pH 7.9, was added 400 pL of a 15 mM ethanolic 
solution of SPDP (6.0 pmol) with vigorous mixing. One 
hour later 500 pL of 1 M sodium acetate, pH 5, was added; 
gel filtration (Sephadex G25,lOO mM sodium acetate, pH 
5) yielded a 2.4 mL solution of 2, containing 0.56 pmol of 
p L y s 2 ~  modified with 5.77 pmol of dithiopyridine linker. 
(C) Conjugation of Peptide withPolylysine. Conjugates 
were prepared by mixing 1.5 pmol of lactosylated peptide 
lb in 3 mL of 20 mM NaCl with 0.146 pmol of modified 
polylysine 2 in 620 pL of 100 mM sodium acetate buffer, 
pH 5, under an argon atmosphere. After the addition of 
100 pL of 2 M HEPES, pH 7.9, the reaction mixture was 
kept for 18 h at room temperature. The salt concentration 
was brought to 0.66 M by addition of NaC1, and conjugates 
were isolated by cation-exchange chromatography (Phar- 
macia Mono S column HR 5/5; gradient elution with buffer 
A, 50 mM HEPES, pH 7.3, and buffer B, buffer A plus 3 
M NaCl). The product fractions were eluted a t  salt 
concentrations around 1.2-1.8 M and pooled. After 
dialysis against 25 mM HEPES, pH 7.3, conjugate 3, 
"(gal)4pL", was obtained, containing 49 nmol of pLys2~0 
modified with ca. 380 nmol of ligand moieties (Le. 1.5pmol 
of lactosamine groups). 
Cells and Transfections. HepG2 cells (ref 20, a kind 
gift of Prof. M. Spiess, Basle) were grown in DMEM plus 
10% FCS, 100 units/mL penicillin, 100 pg/mL strepto- 
mycin, and 2 mM glutamine in 25 cm2 flasks. The mouse 
embryonic liver cell line BNL CL.2 (ATCC TIB 73; ref 21) 
was grown in 6-cm plates in high glucose DMEM (0.4% 
glucose) supplemented with 10 % heat-deactivated FCS, 
with 100 units/mL penicillin, 100 pg/mL streptomycin, 
and 2 mM glutamine a t  37 "C in a 5% COz atmosphere. 
Transfections were performed a t  a density of 300 000- 
400 000 cells per flask (or plate). Before transfection, cells 
were supplied with fresh serum-supplemented medium. 
The cells were harvested for the luciferase assay (3) 24 h 
after transfection. Values shown in the figures represent 
the total luciferase activity in the transfected cells. The 
filled bars represent mean values, the bracket above each 
bar indicates one standard deviation. 
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Figure 1. Artificial galactoside ligand-polylysine conjugate. 
RESULTS 
Synthesis. We wanted to construct a tetra-antennary 
ligand containing four galactoside residues that should 
serve for binding to the asialoglycoprotein receptor. For 
this purpose, the branched peptide la (see Figure 1) was 
prepared by automated solid-phase synthesis using the 
Fmoc procedure (18). Branching a t  the N-terminus was 
the result of coupling two lysines to the a- and €-amino 
groups of a further lysine, utilizing a concept similar to 
that described for the preparation of MAPS (multiple 
antigenic peptides, ref 22). The four amino groups of la 
were modified with lactose (0.6 M lactose, i.e. 12 equiv/ 
peptide; 37 "C) by aldimine formation followed by 
reduction with sodium cyanoborohydride to the secondary 
amines. The resulting glycopeptide lb, containing the 
clustered carbohydrate groups separated from a C-terminal 
cysteine by a 10 amino acid long Gly/Ser spacer sequence, 
was isolated in the reduced, sulfhydryl-containing form. 
Modification of all four amino groups was indicated by a 
ninhydrin assay and confirmed by proton NMR analysis 
and time-of-flight mass spectroscopy. The C-terminal 
cysteine served for coupling to pyridyldithiopropionate- 
modified polylysine 2 (average chain length of ca. 290 
L-lysine monomers per molecule) via disulfide bond 
formation in the next step. Conjugate 3, "(gal)4pL", was 
isolated by ion-exchange chromatography and character- 
ized by determination of lysine and carbohydrate content. 
The conjugate contains, on average, 8 glycopeptide ligands 
per polylysine chain, which corresponds to 1 ligand per 36 
lysine residues. 
As reference compounds, asialofetuin-polylysine con- 
jugates, AFpL, and Ne-lactosylated polylysine, pLys- 
lactose, were synthesized (see Experimental Procedures). 
The synthesis of AFpL conjugates involved the modifi- 
cation of one to two amino groups on the asialofetuin 
molecule with succinimidyl3- (2-pyridyldithio)propionate, 
followed by ligation to similarly modified polylysine 2 
through the formation of disulfide bonds. N'-Lactosylated 
polylysine was prepared by reductive coupling of lactose 
to the polylysine amino groups. The chosen conditions 
U 
3 : (gal)4pL 
(0.6 M lactose, corresponding to 3 equiv of lactose/amino 
group, 37 "C, 60 h) resulted in modification of ca. 75-80% 
of the Ne-lysine amino groups. 
Gene Transfer to Hepatocyte Cultures. We tested 
whether DNA complexed with (gal)4pL would be bound 
by and internalized into cells expressing the hepatocyte- 
specific asialoglycoprotein receptor. Different DNA trans- 
port complexes were prepared by mixing plasmid DNA 
pRSVL [encoding P. pyralis luciferase as a reporter gene, 
under the control of the Rous sarcoma virus long terminal 
repeat enhancer/promoter (l4)1, with either (gal)4pL or 
various other ligand-polylysine conjugates. Under these 
conditions the polylysine moiety of the conjugates neu- 
tralizes alarge proportion (ca. 50-100% ) of the DNA charge 
(see the legend of Figure 2). These complexes were applied 
onto HepG2 cells (which express high levels of the 
asialoglycoprotein receptor); the cells were harvested 24 
h later and assayed for luciferase activity. Expression of 
luciferase (Figure 21, as an indication of successful gene 
transfer into HepG2 cells, was found using transferrin, 
asialofetuin, or the artificial galactose-containing peptide 
as ligands (Figure 2, lanes 1-3), but only if the cells were 
also incubated in the presence of the lysosomatropic agent 
chloroquine, which prevents acidification and activation 
of lysosomal degradative enzymes, but may also act by 
osmotic destabilization of intracellular acidic vesicles upon 
internal accumulation of the agent (2-3,8,23). The highest 
luciferase activities have been obtained with the asialofe- 
tuin conjugates (Figure 2, lane 2) and the synthetic (gal)- 
4pL conjugates (Figure 2, lane 3). Proper structural 
arrangement of the galactosides on the ligand seems to be 
essential for gene transfer. DNA complexed with lacto- 
sylated polylysine (pLys-lactose, see Experimental Pro- 
cedures) was not expressed a t  significant levels (Figure 2, 
lane 4). DNA complexes containing neutralizing or slightly 
higher amounts of unmodified polylysine (Figure 2, lane 
5 )  show low, but significant, receptor-independent uptake 
into HepG2 cells. This unspecific effect of polylysine has 
been observed in certain adherent cell lines in experiments 
a t  low (2% or less) serum levels. 
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Figure 2. Luciferase gene delivery to HepGZ cells using different 
ligand-polylysine conjugates. pRSVL DNA (10 pg) in 330 pL of 
HBS was mixed with the indicated amounts of TfpL19OB 
conjugate, asialofetuin-polylysine AFpL, polylysine (pLysz,), 
or (gal)4pL, in 170 pL HBS. Optimum ratios of DNA/conjugate 
have been determined in preliminary titrations by assaying the 
resulting gene-transfer efficiency (data not shown). The amounb 
(pg) of conjugate or polycation refer, in the case of pLysz~ or 
(gal)4pL, to the content of polylysine calculated as hydrobromide 
salt and, in the case of TfpL (or AFpL), to the transferrin 
(asialofetuin) content. In the competition experiments 240 pg 
(13 equiv) of asialofetuin (AF) or 30 rg (25 equiv) of lactosylated 
peptide (gal)4 was added after 30 min. The DNA complex mixture 
was then added to HepG2 cells (400 000 cells per flask) in 4 mL 
of medium containing 10% FCS; just prior to transfection, 
chloroquine (Sigma) was added to a final concentration of 100 
pM in the transfection medium. The cells were incubated at 37 
"C for 4 h, and then the transfection medium was replaced by 
4 mL of fresh DMEM plus 10% FCS. Harvesting of cells and 
luciferase assays were performed 24 h after transfection as 
previously described (I). Light unit values as shown represent 
the total luciferase activity of the transfected cells. The filled 
bars represent mean values; the bracket above each bar indicates 
one standard deviation. 
We next asked if the delivery of DNA/(gal)4pL com- 
plexes truly involved interactions with the asialoglyco- 
protein receptor. If this is the case, including excess levels 
of free ligand [either (gal)4 peptide or asialofetuinl should 
compete with DNA complexes for receptor binding and 
lower the subsequent luciferase gene expression. We found 
that inclusion of either excess free asialofetuin or free (gal)4 
peptide blocks luciferase gene delivery to these cells (Figure 
2, lanes 6 and 7) indicating that gene delivery occurs by 
binding to the asialoglycoprotein receptor. In this ex- 
periment, where only half of the DNA charge was 
neutralized by (gal)4pL conjugates, the unspecific effect 
of polylysine (compare Figure 2, lane 5) has been largely 
eliminated. 
Augmentation of Gene Delivery by Replication- 
Defective Adenovirus Particles. Gene transfer into 
the murine embryonic hepatocyte line BNL CL.2 is shown 
in Figure 3. Again, complexes containing the hepatocyte- 
specific ligands, AF or (gal)4, showed the highest gene 
transfer activities in the presence of chloroquine (Figure 
3B). In the absence of chloroquine only modest expression 
levels (Figure 3A) near the background of 150-200 light 
units were obtained. Although the plasmid DNA pCMVL, 
containing the P. pyralis luciferase gene under control of 
the more efficient cytomegalovirus immediate-early pro- 
moter/enhancer, was used, the transfection efficiencies 
have been moderate even in the presence of chloroquine. 
An alternate measure to prevent accumulation of the 
delivered DNA in intracellular vesicles is the use of 
replication-defective adenoviruses, which, as a result of 
their endosome-disrupting activity, have been found to 
strongly enhance transferrin-polylysine-mediated gene 
transfer into HeLa cells (9). Addition of adenovirus d1312 
particles to the transfection medium resulted in a strong 
augmentation of gene expression both in BNL CL.2 cells 
(Figure 3C) and HepG2 cells (data not shown). The 
augmentation (30-500-fold over the level of chloroquine- 
augmented transfections, ca. 106-fold over the level of 
control transfections) was most pronounced in the case of 
polylysine-rich DNA complexes (Figure 3C, "(gal)4pL"), 
which tend to bind adenovirus particles by ionic interaction 
between polylysine and the acidic viral capsid proteins 
(our unpublished observations). DNA/transferrin-poly- 
lysine complexes which are physically linked to the virus 
(10) have been found to be a most efficient means for gene 
transfer, as colocalization of the DNA complex and virus 
particle in the same endosome is guaranteed. 
Enhanced Gene Transfer Using DNA Complexes 
Containing Galactose-Ligand and Influenza Pep- 
tides. Polylysine-conjugated peptides containing se- 
quences derived from the N-terminus of the influenza virus 
hemagglutinin HA-2 subunit have been found to sub- 
stantially augment transferrin-polylysine-mediated gene 
transfer (11). We have prepared similar complexes (Figure 
4A) containing the plasmid pCMVL, the tetra-antennary 
galactose ligand linked to polylysine, and the polylysine- 
modified influenza peptide InflupL (see Experimental 
Procedures and ref 11). Conditions were chosen so that 
the ligand-polylysine conjugate neutralized half of the 
DNA charge and the remainder of the charge was used to 
load the complexes with influenza peptide-polylysine 
conjugate. Delivery of these complexes into BNL CL.2 
hepatocytes resulted in luciferase gene expression (Figure 
4B) that was significantly higher than the expression 
obtained with transferrin as ligand. The expression was 
more than 500-fold higher than in control experiments 
using DNA complexes lacking the influenza peptides, but 
containing the same amount of transferrin or (gal)4pL 
conjugates and polylysine (Figure 4B). The activity 
obtained in the presence of the modified influenza peptide 
was ca. 10-fold higher than that obtained with DNA/(gal)- 
4pL complexes incubated with cells in the presence of 
chloroquine (see Figure 3B), and ca. 104-fold higher than 
in the control experiment (Figure 3A). 
DISCUSSION 
Our aim is to develop a synthetic gene transfer system 
based on receptor-mediated endocytosis, a natural mech- 
anism that is utilized for uptake of macromolecules such 
as proteins or viruses into cells. For this purpose, a number 
of groups (4,6,24), including our own, have synthesized 
DNA-binding conjugates of proteins that are ligands for 
cellular receptors. When DNA complexes prepared with 
the iron transporter transferrin, conjugated to polycations 
or other DNA-binding components (1,15), are incubated 
with cells, the complexes bind to transferrin receptors, 
and subsequent uptake into the cells results in expression 
of the gene contained on the DNA (2,25). In many cases 
the protein conjugation chemistry is difficult to control in 
terms of positions and numbers of polycation ligation sites, 
as a consequence of multiple potential reactive groups on 
the large protein ligands. In the case of transferrin 
conjugates, a specific ligation procedure involving mod- 
ification of the transferrin carbohydrate moiety has been 
described (15) which allows defined, site-specific polycation 
attachment. 
Another approach to obtain structurally well-defined 
DNA-binding ligand conjugates is the replacement of large 
protein ligands by smaller, synthetic compounds that 
mimic ligand-binding to a receptor. For this purpose we 
have synthesized an artificial ligand for the asialoglyco- 
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Figure 3. Transfection of BNL CL.2 hepatocytes and its augmentation by the endosome-disruption activity of defective adenovirus 
particles. Solutions of 6 pg of pCMVL DNA in 330 pL of HBS were mixed with the indicated amounts of mouse TfpL290 conjugate, 
asialofetuin-polylysine (AFpL), or (gal)4pL, in 170 pL HBS, and left for 30 min at room temperature. The DNA complexes were added 
to BNL CL.2 cells (300 000 cells per plate) cultured with 1 mL of fresh medium containing 2% FCS without (A) or with (B) chloroquine 
(final concentration 100 pM). Cells were incubated at 37 "C for 2 h, and then 1.5 mL of medium containing 10% FCS without (A) 
or with (B) 100 pM chloroquine was added. Two hours later the transfection medium was replaced by 4 mL of fresh high-glucose 
DMEM plus 10% FCS. (C) Instead of including chloroquine in the cell culture medium, to each DNA/conjugate complex was added 
1 mL of DMEM containing 2 % FCS and 50 pL of adenovirus d1312 stock solution (ca. lo9 viral particles). Incubation of the cells with 
the comDlexes and further manipulations were performed as described above, but in the absence of chloroquine. Assays were performed 
as desciibed in Figure 2. 
protein receptor. This hepatocyte-specific receptor has 
already proven to be suitable for gene delivery using 
asialoorosomucoid-polylysine conjugates (5). The inter- 
action of this receptor with its ligand is well-studied and 
occurs via recognition of (preferentially) three terminal 
galactose residues on the asialoglycoprotein ligand by the 
trimeric subunits of the receptor (7). Triantennary or 
tetra-antennary oligosaccharides (that are present, for 
example, on asialofetuin or asialo-orosomucoid) with three 
or four terminal galactose residues are rapidly endocytosed 
by hepatocytes, whereas there is no evidence of efficient 
endocytosis of biantennary oligosaccharides (26) or asia- 
loglycoproteins containing biantennary oligosaccharides 
(27). The clustering effect has also been described for the 
binding of neoglycoproteins containing covalently attached 
synthetic galactosides a t  various sugar densities (28). 
Synthetic cluster glycosides containing three galactosyl 
or lactosyl residues are bound to the asialoglycoprotein 
receptor and endocytosed by hepatocytes (29,301. 
We have synthesized a tetra-antennary ligand, (gal)4, 
containing galactoside residues bound to a branched 
peptide backbone which should provide appropriate 
structural arrangement of the carbohydrate groups (Figure 
1). This synthetic ligand, if conjugated to polylysine, binds 
to DNA and delivers the gene contained on the DNA into 
cultured hepatocytes. The uptake most likely proceeds 
through binding to the asialoglycoprotein receptor followed 
by endocytosis, because the gene expression can be 
inhibited by addition of compounds that compete for 
binding to the asialoglycoprotein receptor (Figure 2). 
After endocytosis, in the natural context, asialoglyco- 
proteins are targeted to lysosomes and degraded by 
hydrolytic enzymes. The accumulation in lysosomal 
compartments may present a major limit to receptor- 
mediated gene delivery. A related hurdle seems to be 
present in the case of gene transfer by calcium phosphate 
precipitation, where over 50% of the DNA was found 
degraded in lysosomes (31). Nevertheless, successful 
receptor-mediated gene transfer has been found using 
asialoorosomucoid-polylysine conjugates (5, 6). In our 
hands, the expression levels in hepatocyte gene transfer 
experiments with asialofetuin or the (gal14 conjugates were 
very low unless further supporting measures (see below) 
were taken. Some rationalizations for the difference to 
the published data (5,6) are as follows: (i) we are working 
with a slightly different system (ligand, conjugate, reporter 
gene, complex formation, amount of reagents, cell culture 
conditions); (ii) we believe that the gene transfer in the 
published system (5,6) may be considerably augmented 
by the use of supporting agents such as chloroquine or 
adenovirus. In our experiments, efficient gene transfer 
was found when we included either chloroquine, which 
may protect to some extent internalized material from 
lysosomal degradation and/or may destabilize intracellular 
vesicles, or agents that promote the release of internalized 
DNA complexes from endosomes. A particularly effective 
measure consists of the use of defective adenovirus particles 
with endosome-disruption activity (9, 321, which (in 
comparison to chloroquine) results in a 500-fold enhance- 
ment of gene expression mediated by the (gal)Ccontaining 
DNA complexes (Figure 3). 
Instead of using whole viral particles, it would be 
desirable to generate completely synthetic gene transfer 
complexes that utilize cellular mechanisms for entry. We 
intended to separate the endosome-release function of 
viruses from the whole virus particles. In this context, we 
have recently demonstrated that small synthetic peptides 
derived from influenza virus hemagglutinin that are able 
to disrupt membranes specifically under acidic conditions, 
if included in DNA complexes, promote transferrin- 
mediated gene transfer (11). We have shown here that 
DNA complexes containing both the synthetic ligand for 
endocytosis, (gal)4, and the synthetic membrane-active 
influenza peptide can deliver genes to hepatocytes with 
an efficiency approximately 500-fold higher than com- 
plexes lacking the influenza peptide (Figure 41, but still 
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Figure 4. Gene transfer using combination complexes containing 
receptor ligands and membrane-active peptides. (A) Schematic 
drawing of DNA complexes containing both a ligand for en- 
docytosis and a membrane-active component for endosome 
disruption. (B) Luciferase gene transfer into BNL CL.2 hepa- 
tocytes. DNA combination complexes were prepared by mixing 
first 6 pg of pCMVL-DNA in 160 pL of HBS with 4 pg of TfpLnm 
or 2 pg of (gal)4pL in 160 pL of HBS and, after 15-30 min at room 
temperature, subsequent mixing with 20 pg of the influenza HA-2 
N-terminal peptide-poly(L-lysine) conjugate (InflupL) or with 
20 pg of unmodified polyQ-lysine) (pLys), in 160 pL of HBS. 
Addition of the DNA complexes to the cells (in the absence of 
chloroquine) and further treatment of the cultures was performed 
as described in Figure 3A. Cell culture samples were harvested 
and assayed for luciferase activity as described in Figure 2. 
approximately 50-fold lower than with adenovirus particles 
(Figure 3C). Our synthetic ligand for the asialoglycopro- 
tein receptor functions comparably to a natural ligand 
and, with respect to hepatocytes, even better than trans- 
ferrin as ligand in gene-transfer experiments. We hope 
that gene-transfer systems containing synthetic, well- 
defined ligands such as the (gd)4 described here, combined 
in a modular manner with other functional components 
such as synthetic membrane-disrupting peptides, will 
prove useful for targeted gene-transfer applications. 
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